Benjamin Shum

1.5k total citations
6 papers, 140 citations indexed

About

Benjamin Shum is a scholar working on Oncology, Infectious Diseases and Immunology. According to data from OpenAlex, Benjamin Shum has authored 6 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Infectious Diseases and 2 papers in Immunology. Recurrent topics in Benjamin Shum's work include Cancer Immunotherapy and Biomarkers (5 papers), COVID-19 and healthcare impacts (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Benjamin Shum is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), COVID-19 and healthcare impacts (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Benjamin Shum collaborates with scholars based in United Kingdom. Benjamin Shum's co-authors include Samra Turajlic, James Larkin, Lewis Au, Rooshi Nathwani, Ameet Dhar, Kevin Woollard, Cathrin Gudd, Tong Liu, Robert Goldin and David J. Pinato and has published in prestigious journals such as Clinical Cancer Research, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Benjamin Shum

5 papers receiving 139 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Shum United Kingdom	4	92	45	39	36	27	6	140
Patricia Iranzo Spain	7	108 1.2×	30 0.7×	66 1.7×	25 0.7×	34 1.3×	22	158
Ryotaro Ohkuma Japan	9	126 1.4×	51 1.1×	50 1.3×	27 0.8×	14 0.5×	15	174
Rita Balsano Italy	9	90 1.0×	26 0.6×	32 0.8×	87 2.4×	51 1.9×	20	192
Pierre Van Mol Belgium	5	107 1.2×	41 0.9×	98 2.5×	65 1.8×	27 1.0×	10	239
Yuya Hirasawa Japan	8	115 1.3×	48 1.1×	71 1.8×	21 0.6×	17 0.6×	18	172
Alexandre Wicky Switzerland	6	94 1.0×	42 0.9×	43 1.1×	37 1.0×	12 0.4×	16	164
Tomoyuki Ishiguro Japan	6	102 1.1×	48 1.1×	40 1.0×	18 0.5×	13 0.5×	10	129
Tak Loon Khong United Kingdom	7	54 0.6×	27 0.6×	18 0.5×	60 1.7×	52 1.9×	13	159
Luisa Piccin Italy	5	167 1.8×	53 1.2×	69 1.8×	30 0.8×	18 0.7×	16	219
Masaki Sunagawa Japan	6	96 1.0×	38 0.8×	39 1.0×	34 0.9×	16 0.6×	34	144

Countries citing papers authored by Benjamin Shum

Since Specialization

Citations

This map shows the geographic impact of Benjamin Shum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Shum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Shum more than expected).

Fields of papers citing papers by Benjamin Shum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Shum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Shum. The network helps show where Benjamin Shum may publish in the future.

Co-authorship network of co-authors of Benjamin Shum

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Shum. A scholar is included among the top collaborators of Benjamin Shum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Shum. Benjamin Shum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Gérard, Camille L., Benjamin Shum, Paul Nathan, & Samra Turajlic. (2023). Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond. Immuno-Oncology Technology. 19. 100386–100386. 2 indexed citations

2.

Alexander, James L., Hajir Ibraheim, Benjamin Shum, et al.. (2022). Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis. Journal for ImmunoTherapy of Cancer. 10(9). e005490–e005490. 6 indexed citations

3.

Fendler, Annika, Lewis Au, Fiona Byrne, et al.. (2021). 1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study. Annals of Oncology. 32. S1129–S1129. 10 indexed citations

4.

Shum, Benjamin, James Larkin, & Samra Turajlic. (2021). Predictive biomarkers for response to immune checkpoint inhibition. Seminars in Cancer Biology. 79. 4–17. 79 indexed citations

5.

Gudd, Cathrin, Lewis Au, Evangelos Triantafyllou, et al.. (2021). Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. Journal of Hepatology. 75(1). 177–189. 43 indexed citations

6.

Fendler, Annika, Lewis Au, Scott T.C. Shepherd, et al.. (2020). CAPTURE: Cancer and COVID-19 antiviral immune monitoring study. Clinical Cancer Research. 26(18).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact